Effects of hepatitis G virus coinfection on severity of hepatitis C: Relationship to risk factors and response to interferon treatment

Journal of Gastroenterology and Hepatology (Australia)

Volumn 13, Issue 8, 1998, Pages 773-780

  Lin, Rita ^a,b   Dutta, Usha ^a,b   Kaba, Songul ^b   Kench, James ^b   Crewe, Evelyn ^b   Coverdale, Shirley ^a,b   Byth, Karen ^a   Liddle, Christopher ^a   Farrell, Geoffrey C ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

Coinfection; Genotype; Hepatitis C; Hepatitis G; Interferon; Liver histology

Indexed keywords

RECOMBINANT ALPHA2B INTERFERON;

ADULT; ARTICLE; COMORBIDITY; DISEASE SEVERITY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS G VIRUS; HISTOPATHOLOGY; HUMAN; IMMUNOTHERAPY; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS HEPATITIS;

EID: 0031830566     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1998.tb00732.x     Document Type: Article

References (29)

1. Alter MJ, Margolis HS, Krawczynski K et al. The natural history of community-acquired hepatitis C in the United States. N: Engl. J.Med. 1992; 327: 1899-905.
2. Koretz RL, Brezina M, Polito AJ et al. Non-A, non-B post-transfusion hepatitis: comparing C and non-C hepatitis. Hepatology 1993; 17: 361-5.
3. Linnen J, Wages J Jr, Zhang-Keck ZY et al. Molecular cloning and disease progression of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271: 505-9.
4. Alter HJ. The cloning and clinical implications of HGV and HGBV-C. N: Engl. J. Med. 1996; 334: 1356-7.
5. Pilot-Matias TJ, Muerhoff S, Simons JN et al. Identification of antigenic regions in the GB hepatitis viruses GBV-A, GBV-B, and GBV-C. J. Med. Virol. 1996; 48: 329-38.
6. Feucht HH, Zollner B, Polywka S, Laufs R. Vertical transmission of hepatitis G. Lancet 1996; 347: 615-16.
7. Rubio A, Rey C, Sandez-Quijano A et al. Is hepatitis G transmitted sexually? JAMA 1997; 277: 532-3.
8. Jarvis LM, Davidson F, Hanley JP et al. Infection with hepatitis G virus among recipients of plasma products. Lancet 1996; 348: 1352-5.
9. Aikawa T, Sugai Y, Okamoto H. Hepatitis G infection in drug abusers with chronic hepatitis C. N. Engl. J. Med. 1996; 334: 195-6.
10. Masuko K, Mitsui T, Iwano K et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N. Engl. J. Med. 1996; 334: 1485-90.
11. Schleicher S, Chaves RL, Dehmer T et al. Identification of GBV-C hepatitis G RNA in chronic hepatitis C patients. J. Med. Virol. 1996; 50: 71-4.
12. Goeser T, Seipp S, Wahl R et al. Clinical presentation of GB-C virus infection in drug abusers with chronic hepatitis C. J. Hepatol. 1997; 26: 498-502.
13. Chuang WL, Chang WY, Lu SN et al. The role of hepatitis C in chronic hepatitis B infection. Gastroenterol. Jpn. 1993; 28: 23-7.
14. Fuiano B, Pannullo A, Annovazzi G et al. Risk factors and association with HBV infection in chronic C hepatitis, Ital. J. Gastroenterol 1992; 24: 409-11.
15. Weltman MD, Brotodihardjo A, Crewe EB et al. Coinfection with hepatitis B & C or B, C & D viruses results in severe chronic liver disease and responds poorly to interferon treatment. J. Viral Hepat. 1995; 2: 39-45.
16. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J. Hepatol. 1991; 13: 372-4.
17. Coverdale S, Byth K, Field J et al. Antipyrine clearance and response to interferon treatment in patients with chronic active hepatitis C. Hepatology 1995; 22: 1065-71.
18. Lin R, Roach E, Zimmerman M, Strasser S, Farrell GC for the Australian Hepatitis C Study Group. Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. J. Hepatol. 1995; 23: 487-96.
19. Lin R, Schoeman MN, Craig PI et al. Can the response to interferon treatment be predicted in patients with chronic hepatitis C? Aust. NZ J. Med. 1991; 21: 387-92.
20. Davis GL, Lau JYN, Urdea MS et al. Quantitative detection of hepatitis C virus RNA with a solid phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients. Hepatology 1994; 19: 1337-41.
21. Lin R, Liddle C, Byth K, Farrell GC. Virus and host factors are both important determinants of response to interferon treatment among patients with chronic hepatitis C. J. Viral Hepat. 1996; 3: 85-96.
22. Simmonds P, Holmes EC, Cha TA et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS5 region. J. Gen. Virol. 1993; 74: 2391-9.
23. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989; 339: 237-8.
24. Chen JJ, McGuinness PH, Koorey DJ et al. Hepatitis C virus genotypes in a cohort of Australian blood donors and haemophiliac and liver transplant patients. J. Gastroenterol. Hepatol. 1997; 12: 182-7.
25. Tanaka E, Alter HJ, Nakatsuji Y et al. Effect of hepatitis G virus infection on chronic hepatitis C. Ann. Intern. Med. 1996; 125: 740-3.
26. BergT, Dirla U, Naumann U et al. Responsiveness to interferon alpha treatment in patients with chronic hepatitis C coinfected with hepatitis G virus. J. Hepatol. 1996; 25: 763-8.
27. Martinot M, Marcellin P, Boyer N et al. Influence of hepatitis G virus infection on the severity of liver disease and response to interferon in patients with chronic hepatitis C. Ann. Intern. Med. 1997; 126: 874-81.
28. Alter MJ, Gallagher M, Morris T et al. Acute non A-E hepatitis in the United States and the role of hepatitis G virus infection. N. Engl. J. Med. 1997; 336: 741-6.
29. Alter HJ, Nakatsuji Y, Melpolder J et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N. Engl. J. Med. 1997; 336: 747-54.